Humana Inc. (NYSE:HUM) Shares Sold by Rhumbline Advisers

Rhumbline Advisers decreased its position in Humana Inc. (NYSE:HUM - Free Report) by 3.8% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 238,128 shares of the insurance provider's stock after selling 9,522 shares during the period. Rhumbline Advisers owned about 0.20% of Humana worth $60,415,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of the company. State Street Corp increased its stake in shares of Humana by 1.0% in the 3rd quarter. State Street Corp now owns 5,357,420 shares of the insurance provider's stock valued at $1,701,582,000 after purchasing an additional 53,272 shares in the last quarter. FMR LLC grew its holdings in Humana by 23.4% in the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider's stock valued at $1,073,387,000 after purchasing an additional 643,291 shares during the period. Pzena Investment Management LLC increased its position in shares of Humana by 8.1% in the third quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider's stock valued at $793,830,000 after buying an additional 187,903 shares in the last quarter. Ontario Teachers Pension Plan Board increased its position in shares of Humana by 6.5% in the third quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider's stock valued at $371,705,000 after buying an additional 71,910 shares in the last quarter. Finally, Sanders Capital LLC raised its stake in shares of Humana by 1.0% during the 3rd quarter. Sanders Capital LLC now owns 1,168,341 shares of the insurance provider's stock worth $370,060,000 after buying an additional 11,923 shares during the period. Institutional investors and hedge funds own 92.38% of the company's stock.

Analysts Set New Price Targets

Several brokerages recently commented on HUM. Royal Bank of Canada reissued an "outperform" rating and issued a $283.00 price target on shares of Humana in a report on Wednesday, February 12th. Morgan Stanley cut their target price on shares of Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a research note on Wednesday, February 12th. Wells Fargo & Company decreased their price target on shares of Humana from $387.00 to $290.00 and set an "overweight" rating on the stock in a research note on Monday, November 4th. Piper Sandler boosted their price objective on Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a research note on Wednesday, January 15th. Finally, Bank of America upgraded Humana from an "underperform" rating to a "neutral" rating and raised their target price for the company from $247.00 to $308.00 in a research report on Wednesday, November 6th. Nineteen investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $285.68.

Humana Trading Up 2.4 %

Shares of NYSE HUM traded up $6.35 during midday trading on Thursday, reaching $271.87. 1,037,729 shares of the stock were exchanged, compared to its average volume of 1,672,233. The stock has a market capitalization of $32.74 billion, a P/E ratio of 27.32, a PEG ratio of 1.94 and a beta of 0.56. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The company has a 50 day simple moving average of $269.80 and a 200 day simple moving average of $291.28. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $406.46.

Humana (NYSE:HUM - Get Free Report) last posted its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. As a group, equities analysts expect that Humana Inc. will post 16.49 earnings per share for the current year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.30%. Humana's payout ratio is currently 35.58%.

Insiders Place Their Bets

In other news, insider Timothy S. Huval sold 3,703 shares of the company's stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.32% of the stock is currently owned by insiders.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.